CANCER DRUG DEVELOPMENT COMES OF AGE
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 May 2022)
What this means for you
This application is over — abandoned 02 May 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90127064
- Mark type
- Stylized text
- Filed
- 20 Aug 2020
- Published for opposition
- 02 Feb 2021
- Abandoned
- 02 May 2022
- Attorney of record
- David Ewen
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- Day One Biopharmaceuticals, Inc., MENLO PARK, CA, US
- Day One Therapeutics, Inc., Menlo Park, CA, US
Prosecution history
- 02 May 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 May 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Feb 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Feb 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 15 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Feb 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Sept 2021 — SOU EXTENSION 1 GRANTED
- 22 Sept 2021 — SOU EXTENSION 1 FILED
- 28 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 24 Apr 2021 — CORRECTED NOA E-MAILED
- 23 Apr 2021 — POST PUBLICATION AMENDMENT - ENTERED